Retrospective study finds significant improvements in glycemic metrics for patients using continuous glucose monitoring.
Introduction: To compare diabetes metrics in patients hospitalized in Internal Medicine for acute respiratory or septic event between those who used traditional glycemic monitoring (DTX) or continuous glucose monitoring (CGM).Methods: Retrospective study of a cohort of 180 patients hospitalized between April-December 2023, 90 of whom were monitored using CGM and comparison of their glycemic parameters with other 90 patients with a similar admission diagnosis who were monitored using DTX. In Dexcom group we evaluated mean glycemia (MBG), standard deviation (SD) of MBG, glycemic coefficient of variability (CV), time in range (TIR% 70-180 mg%), time above range (TAR% >180 mg%), time below range (TBR% <70 mg%). For DTX group we evaluated MBG as mean of daily glycemic values (on average 4,5 DTX samples/day), CV as SD/MBG, TIR as% of DTX values between 70-180 mg%, TAR as% of DTX >80 mg% and TBR as a% of DTX <70 mg%.Results: Levene’s test suggested homogeneity of variances for most of the metrics, with p-values >0.05, indicative of no significant variability discrepancy, except for TBR. T-test unveiled substantial disparities between the groups: MBG demonstrated a significant mean difference (p <0.05), underscoring a substantial divergence in average blood glucose levels. Other parameters, including CV, TIR, and TAR, also manifested statistically significant differences.Conclusion: Our experience highlights a significant difference in terms of glycemic metrics between patients monitored using CGM and those with DTX, the former improving TIR, TBR and CV.
No takes yet. Share an insight, caveat, or question.
A 2025 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: